{
    "2019-08-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm",
                "features": {
                    "keywords": [
                        "Investigation",
                        "Novartis AG",
                        "Claims",
                        "Losses"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Novartis AG â€“ NVS",
                "features": {
                    "keywords": [
                        "Equity Alert",
                        "Rosen Law Firm",
                        "Securities Claims",
                        "Novartis AG"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-16",
                "original_text": "AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "JAK Inhibitor",
                        "Rinvoq",
                        "FDA Approval",
                        "RA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "5 Biggest New Drug Approvals Potentially on the Way in 2019",
                "features": {
                    "keywords": [
                        "Drug Approvals",
                        "2019"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-22",
                "original_text": "Novartis to answer U.S. Senate demand for data manipulation details",
                "features": {
                    "keywords": [
                        "Novartis",
                        "U.S. Senate",
                        "Data Manipulation"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-06-15",
                "original_text": "Novartis executive sold almost $1m shares ahead of FDA probe",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Executive",
                        "Shares",
                        "FDA Probe"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-05-25",
                "original_text": "Novartis faces further fallout over Zolgensma",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Fallout",
                        "Zolgensma"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}